Cargando…
ABCB5(+) mesenchymal stromal cells therapy protects from hypoxia by restoring Ca(2+) homeostasis in vitro and in vivo
BACKGROUND: Hypoxia in ischemic disease impairs Ca(2+) homeostasis and may promote angiogenesis. The therapeutic efficacy of mesenchymal stromal cells (MSCs) in peripheral arterial occlusive disease is well established, yet its influence on cellular Ca(2+) homeostasis remains to be elucidated. We ad...
Autores principales: | Yan, Kaixuan, Zheng, Jiaxing, Kluth, Mark Andreas, Li, Lin, Ganss, Christoph, Yard, Benito, Magdeburg, Richard, Frank, Markus H., Pallavi, Prama, Keese, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912525/ https://www.ncbi.nlm.nih.gov/pubmed/36759868 http://dx.doi.org/10.1186/s13287-022-03228-w |
Ejemplares similares
-
Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5(+) Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa
por: Niebergall-Roth, Elke, et al.
Publicado: (2023) -
Skin-Derived ABCB5(+) Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine
por: Niebergall-Roth, Elke, et al.
Publicado: (2022) -
Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete
and durable wound closure in recessive dystrophic epidermolysis bullosa
[Cytotherapy 25 (2023) 782–788/1562]
por: Dieter, Kathrin, et al.
Publicado: (2023) -
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials
por: TAPPENBECK, NILS, et al.
Publicado: (2019) -
Process data of allogeneic ex vivo-expanded ABCB5(+) mesenchymal stromal cells for human use: off-the-shelf GMP-manufactured donor-independent ATMP
por: Ballikaya, Seda, et al.
Publicado: (2020)